EML
Home
Recent Updates
Favourites
Search
Directory
Guidelines
Medicines
Tools
About
Feedback
Disclaimer
Directory
Guidelines
Search
Medicines
Tools
Antineoplastic and Immunomodulating Agents
Idarubicin
ATC Code
Indication
NEMLC Recommendation
Review Indicators
Date Ratified
ATC CODE
L01DB06
INDICATION
Acute Myeloid Leukemia.
NEMLC RECOMMENDATION
Approved
REVIEW INDICATORS
n/a
DATE RATIFIED
10 December 2015